Telmisartan dispersible tablets market is anticipated to grow at a CAGR of 3.2% during the forecast period. Telmisartan dispersible tablets are the type of medications used to treat high blood pressure (hypertension). Telmisartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. The rising incidence of hypertension globally is the major factor accelerating the growth of the global telmisartan dispersible tablets market. In addition, rising expenditure on health, an increase in cardiovascular diseases, and growing tobacco users are fueling the growth of the market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/telmisartan-dispersible-tablets-market
According to WHO (World Health Organization), more than 1.13 billion people are suffering from hypertension globally, among them, only 1 in each 5 is cured or under control. Among global mortality cases records, hypertension shares 12.8% of all, which means 7.5 billion mortality cases are recorded due to high blood pressure or hypertension. However, the market growth can be hampered by the lack of awareness regarding the use of antihypertensive drugs such as telmisartan dispersible tablets among the population living in rural areas. Apart from these, the introduction of novel drug/therapeutic compounds with disease-modifying capabilities and better effectiveness by major players can bring new growth opportunities to the market during the forecast period.
A full report of Telmisartan Dispersible Tablets Market available @ https://www.omrglobal.com/industry-reports/telmisartan-dispersible-tablets-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Telmisartan Dispersible Tablets Market by Product Type
- 80 mg
- 40 mg
Global Telmisartan Dispersible Tablets Market by Distribution Channel
- Online Sales
- Offline Sales
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories
- Astellas Pharma Inc.
- Bayer AG
- Beijing Wansheng Pharmaceutical
- Boehringer Ingelheim Ltd.
- Reddy’s Laboratories Ltd
- GSK Plc
- Hema Pharmaceuticals Pvt. Ltd.
- Mylan N.V.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global telmisartan dispersible tablets market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/telmisartan-dispersible-tablets-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
